Physician profile
Krista A Ellison
NPI 1902389638
$4,942.07
in general payments reported to CMS, 2019-2025
24 companies · $2,535 in 2025
The $2,535 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $649 · 2022: $493 · 2023: $630 · 2024: $634 · 2025: $2,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,424 · Travel and Lodging: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,423.72 |
| Travel and Lodging | $1,376.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,466.84 | 2025 | Interstim |
| Merck Sharp & Dohme LLC | $730.22 | 2021-2024 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $293.61 | 2021-2024 | Lynparza |
| Sumitomo Pharma America, INC. | $258.95 | 2024-2025 | Gemtesa, Orgovyx |
| Seagen INC. | $233.82 | 2021-2023 | Tivdak |
| Eisai INC. | $223.85 | 2022-2024 | |
| Glaxosmithkline, LLC. | $217.58 | 2021-2024 | Zejula |
| Abbvie INC. | $179.51 | 2024-2025 | |
| Coloplast Corp | $170.77 | 2025 | |
| Procept Biorobotics Corporation | $169.84 | 2024-2025 | Aquabeam System |
| Myriad Genetic Laboratories, INC. | $151.74 | 2023-2025 | Mychoice Cdx, Prolaris |
| Pfizer INC. | $140.77 | 2024 | |
| Progenics Pharmaceuticals, INC. | $105.68 | 2025 | |
| Endo USA, INC. | $102.81 | 2025 | Xiaflex, Aveed |
| Tempus Ai, INC | $99.02 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $95.36 | 2021 | |
| Novartis Pharmaceuticals Corporation | $85.09 | 2021-2025 | |
| Abc Home Medical Supply, INC. | $53.77 | 2025 | |
| Olympus America INC. | $40.14 | 2025 | Uropass, Itind System |
| Hologic Sales and Service, LLC | $38.17 | 2021-2022 | |
| Masimo Corporation | $25.06 | 2025 | Set and Rainbow Set |
| Bayer Healthcare Pharmaceuticals INC. | $24.16 | 2021 | |
| Beigene USA, INC. | $19.67 | 2024 | Brukinsa |
| Janssen Biotech, INC. | $15.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Ellison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.